{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T14:03:21Z","timestamp":1782741801926,"version":"3.54.5"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.yebeh.2006.04.022","type":"journal-article","created":{"date-parts":[[2006,9,8]],"date-time":"2006-09-08T19:52:19Z","timestamp":1157745139000},"page":"448-456","source":"Crossref","is-referenced-by-count":32,"title":["Efficacy, safety, and tolerability of oxcarbazepine monotherapy"],"prefix":"10.1016","volume":"9","author":[{"given":"Walter","family":"Martinez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Ingenito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Blakeslee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory L.","family":"Barkley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"McCague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"D\u2019Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2006.04.022_bib1","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1212\/WNL.54.12.2245","article-title":"Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial","volume":"54","author":"Beydoun","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2006.04.022_bib2","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1212\/WNL.57.5.864","article-title":"Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures","volume":"57","author":"Sachdeo","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2006.04.022_bib3","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1212\/WNL.52.4.732","article-title":"Oxcarbazepine: double-blind, randomized, placebo-control, monotherapy trial for partial seizures","volume":"52","author":"Schachter","year":"1999","journal-title":"Neurology"},{"issue":"Suppl. 2","key":"10.1016\/j.yebeh.2006.04.022_bib4","first-page":"A391","article-title":"Safety and efficacy of oxcarbazepine 1200mg\/day in patients with recent onset partial epilepsy","volume":"52","author":"Sachdeo","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2006.04.022_bib5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0920-1211(97)00025-9","article-title":"A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy","volume":"27","author":"Guerreiro","year":"1997","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2006.04.022_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0920-1211(97)00024-7","article-title":"A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy","volume":"27","author":"Bill","year":"1997","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2006.04.022_bib7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0920-1211(89)90070-3","article-title":"A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy","volume":"3","author":"Dam","year":"1989","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2006.04.022_bib8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0920-1211(96)01013-3","article-title":"A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy","volume":"26","author":"Christe","year":"1997","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2006.04.022_bib9","doi-asserted-by":"crossref","unstructured":"Sachdeo RC, Gates JR, Bazil CW, et al. Improved quality of life in patients with partial seizures after conversion to oxcarbazepine monotherapy. Epilepsy Behav 2006;8: in press.","DOI":"10.1016\/j.yebeh.2006.04.021"},{"key":"10.1016\/j.yebeh.2006.04.022_bib10","unstructured":"Oxcarbazepine (Trileptal\u00ae) prescribing information, Novartis Pharmaceuticals Physicians Desk Reference 2005. Thompson Healthcare, Montvale, NJ."},{"key":"10.1016\/j.yebeh.2006.04.022_bib11","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/seiz.2000.0442","article-title":"Epilepsy after the first drug fails: substitution or add-on?","volume":"9","author":"Kwan","year":"2000","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2006.04.022_bib12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0920-1211(03)00080-9","article-title":"The KEEPER\u2122 trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study","volume":"54","author":"Morrell","year":"2003","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2006.04.022_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1517\/14656566.3.1.59","article-title":"Oxcarbazepine","volume":"3","author":"Beydoun","year":"2002","journal-title":"Expert Opin Pharmacol"},{"key":"10.1016\/j.yebeh.2006.04.022_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0920-1211(94)90091-4","article-title":"Survey of 260 epileptic patients treated with oxcarbazepine (Trileptal\u00ae) on a named-patient basis","volume":"19","author":"Van Parys","year":"1994","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2006.04.022_bib15","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1528-1157.1995.tb00958.x","article-title":"Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system: II. Modulation of high-voltage-activated calcium currents","volume":"36","author":"Stefani","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2006.04.022_bib16","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1212\/WNL.43.4.688","article-title":"Felbamate monotherapy for partial-onset seizures: an active-control trial","volume":"43","author":"Faught","year":"1993","journal-title":"Neurology"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505006001776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505006001776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,21]],"date-time":"2019-04-21T02:50:17Z","timestamp":1555815017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505006001776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S1525505006001776"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2006.04.022","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}